FivePrime is disÂcovÂerÂing and develÂopÂing novel therÂaÂpeuÂtic proÂteins and antiÂbodÂies by sysÂtemÂatÂiÂcally screenÂing all relÂeÂvant proÂteins in the human body to find the best proÂtein for treatÂment of a given clinÂiÂcal indiÂcaÂtion. FivePrimeâ??s ProÂScreen Engine enables the rapid proÂducÂtion and screenÂing of all therÂaÂpeuÂtiÂcally relÂeÂvant proÂteins in medically-â??â??focused assays at the highÂest qualÂity stanÂdards in the indusÂtry. This powÂerÂful approach is the polar oppoÂsite of the industryâ??s traÂdiÂtional â??one proÂtein at a timeâ??. The ProÂScreen Engine comÂprises the definÂiÂtive proÂtein colÂlecÂtion and screenÂing process for bioÂlogÂics disÂcovÂery and is unpreceÂdented in its effiÂciency, qualÂity, and scale. In addiÂtion to DBL Investors, investors include Domain AssoÂciates, VerÂsant VenÂtures, Kleiner Perkins CauÂfield and Byers, Texas Pacific Group, HealthÂCap, and Advanced Tec